KLR Investment Advisors’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CCM
GCM
RIM
CAM
KLR Investment Advisors's LMAT Position: Q1 2024 in Review
KLR Investment Advisors reduced its LeMaitre Vascular (LMAT) stake by 10% in Q1 2024, selling an estimated $38.1K and leaving 5,564 shares worth $349K. The position accounts for 0.25% of the portfolio, ranked #117.
KLR Investment Advisors first reported a position in LMAT in Q2 2023 and has held it in 3 quarters since. The position peaked at $357K in Q2 2023. 243 funds tracked by Wall St. Rank hold LMAT as of Q1 2024.
- KLR Investment Advisors held 5,564 shares of LeMaitre Vascular worth $349K as of Q1 2024.
- KLR Investment Advisors sold 618 LeMaitre Vascular shares in Q1 2024, an estimated $38.1K.
- LeMaitre Vascular made up 0.25% of KLR Investment Advisors's portfolio in Q1 2024, its #117 holding.
- KLR Investment Advisors first reported a position in LeMaitre Vascular in Q2 2023 and has held it in 3 quarters since.
- KLR Investment Advisors's LeMaitre Vascular position peaked at $357K in Q2 2023.
- 243 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2024.
Based on KLR Investment Advisors's 13F filing for Q1 2024, filed 23 Apr 2024.